Clinical Trial Update: The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel)

View source ↗

Summary

This clinical trial update examines the role of macular pigment carotenoids in the pathogenesis and potential treatment of Macular Telangiectasia Type 2 (Idiopa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Telangiectasia Type

Snippet

Sponsor: Paul S. Bernstein | Conditions: Idiopathic Juxtafoveal Telangiectasia | Status: COMPLETED